Register for streaming realtime charts, analysis tools, and prices.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Celgene Corporation (CELG)
Celgene Corporation (CELG) News

CELG

Celgene (CELG)

Celgene Corporation

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CELG

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next >>

Date	Time	Source	Headline	Symbol	Company
03/29/2019	9:09AM	Dow Jones News	Celgene Gets CHMP Positive Opinions for Revlimid, Imnovid Combos in Multiple Myeloma	NASDAQ:CELG	Celgene Corporation
03/29/2019	8:12AM	Business Wire	Celgene Receives CHMP Positive Opinions for Both REVLIMID® (lenalidomide) & IMNOVID® (pomalidomide)-Based Triplet Combinati...	NASDAQ:CELG	Celgene Corporation
03/26/2019	5:03PM	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:CELG	Celgene Corporation
03/26/2019	7:57AM	Dow Jones News	Bristol-Myers, Celgene Get FTC Request For More Info	NASDAQ:CELG	Celgene Corporation
03/26/2019	7:22AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CELG	Celgene Corporation
03/26/2019	7:20AM	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:CELG	Celgene Corporation
03/26/2019	7:04AM	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:CELG	Celgene Corporation
03/25/2019	5:28PM	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:CELG	Celgene Corporation
03/25/2019	4:30PM	Business Wire	Celgene Submits Application to FDA for Ozanimod for the Treatment of Relapsing Forms of Multiple Sclerosis	NASDAQ:CELG	Celgene Corporation
03/25/2019	6:59AM	Business Wire	Bristol-Myers Squibb Board of Directors Sends Letter to Shareholders Highlighting the Compelling Strategic & Financial Ration...	NASDAQ:CELG	Celgene Corporation
03/19/2019	5:26PM	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:CELG	Celgene Corporation
03/19/2019	7:08AM	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:CELG	Celgene Corporation
03/19/2019	7:03AM	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:CELG	Celgene Corporation
03/18/2019	5:24PM	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:CELG	Celgene Corporation
03/15/2019	5:26PM	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:CELG	Celgene Corporation
03/13/2019	5:22PM	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:CELG	Celgene Corporation
03/12/2019	5:29PM	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:CELG	Celgene Corporation
03/12/2019	4:30PM	Business Wire	Celgene Provides Update on ABRAXANE® Combination Therapy in the Treatment of Metastatic Triple-Negative Breast Cancer & Panc...	NASDAQ:CELG	Celgene Corporation
03/12/2019	4:07PM	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:CELG	Celgene Corporation
03/11/2019	7:30AM	Business Wire	Celgene Submits Application to EMA for Ozanimod for the Treatment of Relapsing-Remitting Multiple Sclerosis	NASDAQ:CELG	Celgene Corporation
03/08/2019	5:27PM	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:CELG	Celgene Corporation
03/08/2019	5:05PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CELG	Celgene Corporation
03/08/2019	7:02AM	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:CELG	Celgene Corporation
03/08/2019	6:03AM	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:CELG	Celgene Corporation
03/07/2019	4:46PM	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:CELG	Celgene Corporation
03/07/2019	4:23PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CELG	Celgene Corporation
03/06/2019	7:06AM	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:CELG	Celgene Corporation
03/06/2019	7:03AM	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:CELG	Celgene Corporation
03/06/2019	7:02AM	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:CELG	Celgene Corporation
03/05/2019	4:09PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CELG	Celgene Corporation

Showing the most relevant articles for your search:NASDAQ:CELG

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next >>

Kraig Biocraft Laborator... (QB)

Voip Pal Com (QB)

Net Savings Link (PK)

ERHC Energy (CE)

Rennova Health (PK)

Northwest Biotherapeutics (QB)

Lightwave Logic

Asia Broadband (PK)

Digital Brand Media and ... (PK)

Ethema Health (PK)

SMC Entertainment (PK)

Anavex Life Sciences

Fannie Mae (QB)

Intergrated Cannabis Sol... (PK)

Delayed Upgrade Clock